Integrated Wellness · Research education
Compare the science.
Put two to four molecules side by side. Similar goals do not mean similar mechanisms, evidence or risks.
Choose your molecules
2 of 4 selected · Choose at least 2
Explore a comparison:
On smaller screens, scroll the table sideways to see each molecule.
| Research dimension | BPC-157 Preclinical | TB-500 Preclinical |
|---|---|---|
| Biological classification | Synthetic pentadecapeptide (15 amino acids) | Thymosin-beta-4-related fragment label |
| Mechanism & pathway | Preclinical experiments investigate changes in angiogenic and growth-factor signaling during tissue repair. These proposed pathways do not establish a clinically validated receptor target or a healing effect in humans. | A label used for thymosin-beta-4-related peptides, including the LKKTETQ fragment described by FDA. Full-length thymosin beta-4 participates in actin regulation; fragment activity and product identity require separate evidence. |
| Investigated applications | Tendon, ligament, muscle and gastrointestinal injury models. | Cell migration and tissue-repair hypotheses. |
| Evidence quality | Preclinical | Preclinical |
| What remains uncertain | A review of predominantly rodent studies cannot establish healing benefits in people. Small human reports do not replace adequately controlled trials. | The cited review concerns full-length thymosin beta-4. Its human research cannot be transferred to the TB-500 fragment; direct fragment evidence is limited. |
| Safety considerations | FDA identifies potential immunogenicity and peptide-impurity risks and insufficient human safety information. Long-term effects and interactions are unknown. | FDA identifies no human exposure data for the nominated LKKTETQ fragment and notes immunogenicity and impurity concerns. TB-500 names may refer to differing products. |
| Regulatory classification | Not FDA-approvedNo FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval. | Not FDA-approvedNo FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval. |
Comparing molecules is not a recommendation to combine them. Clinical evidence for one product or indication cannot establish another’s safety or effectiveness. Open each profile for study types, source links and important evidence limitations.